Lexicomp Cost in 2026: What UpToDate Lexidrug Actually Costs

The short answer: Lexicomp is now sold as UpToDate Lexidrug, and there is no free tier. The clearest published figure is the mobile subscription: Apple's US App Store listing for UpToDate Lexidrug shows in-app subscriptions at $29.99 and states that the subscription renews at $29.99 per month after the trial, which works out at roughly $360 across a year. Institutional pricing is not published at all. Most clinicians who use Lexicomp never pay for it personally, because their hospital, health system or medical library holds the license.

That gap between a visible app price and an invisible institutional price is the reason this question is so hard to answer online. Search for the cost and you get software directory pages quoting confident monthly figures that Wolters Kluwer has never published, sitting next to library guides that list the product as free because the library already bought it. Both are describing something real. Neither tells you what you would actually pay.

How much does Lexicomp cost?

For an individual buying it themselves, the number you can verify is $29.99 a month. Apple's US App Store listing for UpToDate Lexidrug shows the in-app subscription packages, still carrying the older Lexicomp naming (Lexicomp Professional Package and Lexi-COMPLETE), at $29.99, and the listing states the subscription renews at $29.99 per month once the trial ends. Held for twelve months that is about $360, which puts it in the same bracket as a mid-range clinical reference rather than a cheap utility app.

For an organization, there is no list price. Lexidrug is sold to hospitals, health systems, pharmacy schools and libraries on negotiated contracts, and what you pay turns on user count, which content sets you take, contract length and what else you already buy from Wolters Kluwer. The company sells UpToDate, Lexidrug and Medi-Span, so a Lexidrug quote is often really a bundle conversation, and the standalone number on its own is close to meaningless.

We do not repeat the per-month figures that circulate on software listing sites, for the same reason we refuse to quote a list price for Micromedex in our breakdown of what Micromedex costs. Those numbers are not published by the vendor and cannot be checked at source. A figure you cannot verify is worse than no figure, because it anchors your expectations before the first call.

Is Lexicomp free?

No. Unlike Epocrates, which keeps a genuinely usable free registered tier covering drug monographs, an interaction checker and a pill identifier, Lexidrug has no free version for practicing clinicians. There is a trial on the mobile app, and after it the subscription bills.

What confuses people is that a very large number of US clinicians use it at no personal cost. If you work in a hospital, if you trained at an academic medical center, or if you have borrowing rights at a medical library, there is a good chance the license is already paid for and you simply sign in with your institutional credentials. Being free to you and being a free product are different things, and the app store price is the one that applies if nobody else is paying.

Why the price is hard to find: Lexicomp is now Lexidrug

Wolters Kluwer rebranded Lexicomp as UpToDate Lexidrug, and the vendor store and university library guides now list it as "UpToDate Lexidrug (formerly Lexicomp)". Half the material written about the product uses one name and half uses the other, and the mobile app compounds it by still selling packages under the old Lexicomp labels. So a search for "Lexicomp cost" surfaces pages written before the rename, pages written after it, and app store screens that mix both, none of which announce that they are all the same product.

If you are researching this, search both names. If you are talking to the vendor, ask about Lexidrug. And if a colleague tells you their hospital has Lexicomp, take it at face value: they have Lexidrug access under a current contract.

Does Lexicomp have an app, and does the app cost extra?

It does, published on the Apple App Store and Google Play as UpToDate Lexidrug. The app is where the only published individual price lives, so in a sense the app is the product for anyone buying personally.

If your organization licenses Lexidrug, you do not buy in the app. You download it and authenticate against the institutional subscription, usually with the same credentials you use for UpToDate. It is worth doing this deliberately, because clinicians routinely pay $29.99 a month in the app on a phone while holding a fully paid institutional entitlement they never activated.

Check what you already have before you pay

This is the part that saves real money, and it takes about five minutes. Before subscribing personally, do three things. Open your EHR and look for a drug reference link in the medication activity, because Wolters Kluwer sells Lexidrug with integrations into Epic, MEDITECH and Cerner and many systems surface it as a context link inside the chart rather than as a separate app. Then check your medical library's database list, where it will be filed under either name. Then ask your pharmacy department, which almost always knows exactly what the organization licenses.

Practices and small groups should run the same check in the other direction. Recurring software charges on a corporate card are the least reviewed line in most medical practices, and the same discipline that gets applied to categorizing every recurring charge a business actually makes is worth applying to clinical content subscriptions. It is common to find three clinicians expensing personal subscriptions to a product the group already licenses at a lower per-seat rate, and equally common to find a renewal for seats nobody has logged into in a year.

What drives an institutional Lexidrug quote

Four variables move the number more than anything else.

User population. Institutional clinical content is usually priced against how many people could use it, not how many do. If nobody has compared actual logins to the licensed count, that comparison is normally the highest-return hour anyone spends on the contract.

Content sets. Lexidrug is modular. What a community hospital needs is not what an academic medical center with a pediatric service and a drug information center needs, and you pay for the configuration you take.

Bundling. Because UpToDate, Lexidrug and Medi-Span come from the same vendor, the standalone Lexidrug price is rarely the best available price. In July 2026 Wolters Kluwer and Epic announced a combined offering packaging Lexidrug with Medi-Span and patient education into a single integrated procurement, pitched particularly at rural hospitals, federally qualified health centers and smaller practices without the informatics staff to validate three separate tools. If you are buying any two of those things, price the bundle before you price the parts.

Timing. These are annual contracts, which means you have leverage roughly once a year and none in between. Start the conversation before the renewal notice arrives, not after.

Lexicomp cost compared to the alternatives

Here is how the published individual pricing lines up as of August 2026. Institutional pricing for all of these is negotiated separately and is not comparable in a table.

On annual cost, Epocrates is the clear winner among the drug references: $179.99 a year against roughly $360 for twelve months of Lexidrug, and it has a free tier that covers a lot of everyday lookups. What that comparison hides is depth. Lexidrug carries the monograph detail pharmacists verify orders against, and Epocrates does not pretend to. We put the two side by side, honestly, in Epocrates vs Lexicomp, and cover the cheaper reference in detail in our breakdown of what Epocrates costs.

Is Lexicomp worth paying for?

It depends entirely on the standard your work gets held to. If you are an ambulatory prescriber checking a dose or an interaction a few times a day, the free Epocrates tier covers most of it and $360 a year is hard to justify. If you are a pharmacist, a hospitalist, or anyone whose orders are verified by a pharmacy team working from Lexidrug, then you are better off reading the same source they are, and the subscription pays for itself the first time it prevents a disagreement about a dosing edge case.

The middle case is the interesting one: clinicians who need more than Epocrates occasionally, but not daily. For them the honest answer is usually to use the free tier routinely and lean on an institutional Lexidrug license for the hard questions, rather than carrying two paid subscriptions. If you are weighing a switch rather than an addition, we lay out what a Lexicomp alternative actually needs to do, and the wider field is in our guide to the best clinical decision support software.

What none of these subscriptions do for you

Every product in that table answers a question you think to ask. None of them watches the prescription you are about to sign and tells you, without being asked, that this patient is already on something that interacts with it, that their kidney function makes the standard dose wrong, or that a documented allergy rules out the obvious choice. To get that from a drug reference you have to run four separate lookups and know in advance that all four are worth running.

That is the gap Prescriber.io is built for. You enter the drug or the scenario once and it checks for drug-drug interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments, and suggests guideline-based alternatives, together in one card with a cited source on each flag. It is decision-support, not autonomous prescribing: every flag is a prompt for a licensed clinician who reviews it, verifies it against official sources, and signs.

Prices verified against vendor and app store listings in August 2026. Subscription pricing changes, and institutional rates are negotiated individually, so confirm the current figure with the vendor before you buy.